OPTUM INFUSION SERVICES 308, LLC

Optum Infusion Services 308, LLC specializes in the compounding and manufacturing of sterile oncology pharmaceutical preparations for specialized clinical environments. The contractor delivers customized, patient-specific chemotherapy and immunotherapy formulations under strict aseptic conditions, aligning with USP <797> and <800> standards for hazardous drug handling. Their technical expertise centers on sterile compounding workflows, oncology drug formulation, and pharmacy supply chain logistics tailored to VA and federal network pharmacy systems. Differentiators include precision dosing for complex regimens, adherence to FDA and state board regulations, and integration with institutional electronic health records to support safe, traceable medication delivery. The contractor maintains a consistent relationship with the Department of Veterans Affairs, providing compounded oncology medications through regional pharmacy hubs such as Dallas and Amarillo, indicating deep integration into VA’s national specialty pharmacy network. They also serve the Network Contract Offices 16 and 17, suggesting participation in centralized procurement frameworks that support VA and other federal healthcare delivery systems. This pattern reflects a focus on mission-critical, high-acuity pharmaceutical services within government-managed care environments. Their primary industry focus is pharmaceutical preparation manufacturing under NAICS 325412, where they operate as a niche provider of compounding services rather than mass production. This vertical specialization positions them as a critical enabler of personalized cancer care within federal healthcare infrastructure, bridging the gap between institutional pharmacy needs and complex oncology treatment protocols. As a 2L entity based in Chandler, Arizona, Optum Infusion Services 308, LLC operates as a mid-tier contractor with no public certifications on record. Their geographic presence is centered in the Southwest, with operational reach extending to VA facilities through regional pharmacy contracts. They are positioned as a specialized, mission-aligned provider within the federal pharmaceutical supply chain, serving high-compliance, low-volume, high-impact clinical needs.